The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 9, 2022 | Kendrick Charles Morgan JR | EVP & President, Commercial | Option exercise(M) | 3K | $271.27 | $753K |
| Jun 9, 2022 | Kendrick Charles Morgan JR | EVP & President, Commercial | Option exercise(M) | 568 | $232.04 | $132K |
| Jun 9, 2022 | Kendrick Charles Morgan JR | EVP & President, Commercial | Option exercise(M) | 987 | $311.48 | $307K |
| Jun 9, 2022 | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell(S) | 3K | $488.64 | $1.3M |
| Jun 9, 2022 | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell(S) | 784 | $489.49 | $384K |
| Jun 9, 2022 | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell(S) | 522 | $490.83 | $256K |
| Jun 9, 2022 | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell(S) | 206 | $491.39 | $101K |
| Jun 9, 2022 | Kendrick Charles Morgan JR | EVP & President, Commercial | Option exercise(M) | 2K | $307.68 | $615K |
| Jun 9, 2022 | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell(S) | 2K | $487.45 | $1.1M |
| Jun 9, 2022 | Kendrick Charles Morgan JR | EVP & President, Commercial | Option exercise(M) | 568 | — | $0 |
| Jun 9, 2022 | Kendrick Charles Morgan JR | EVP & President, Commercial | Option exercise(M) | 2K | — | $0 |
| Jun 9, 2022 | Kendrick Charles Morgan JR | EVP & President, Commercial | Option exercise(M) | 3K | — | $0 |
| Jun 9, 2022 | Kendrick Charles Morgan JR | EVP & President, Commercial | Option exercise(M) | 987 | — | $0 |
| Jun 6, 2022 | Dixon Robert L JR | Director | Sell(S) | 420 | $497.14 | $209K |
| May 19, 2022 | Peru Ramiro G | Director | Sell(S) | 990 | $468.88 | $464K |
| May 18, 2022 | Dixon Robert L JR | Director | Grant(A) | 440 | — | $0 |
| May 18, 2022 | Jallal Bahija | Director | Grant(A) | 440 | — | $0 |
| May 18, 2022 | Schneider Ryan M. | Director | Grant(A) | 440 | — | $0 |
| May 18, 2022 | Tallett Elizabeth E | Director | Grant(A) | 440 | — | $0 |
| May 18, 2022 | Clark R Kerry | Director | Grant(A) | 440 | — | $0 |
| May 18, 2022 | Peru Ramiro G | Director | Grant(A) | 440 | — | $0 |
| May 18, 2022 | Hay Lewis III | Director | Grant(A) | 440 | — | $0 |
| May 18, 2022 | DeVore Susan D. | Director | Grant(A) | 440 | — | $0 |
| May 18, 2022 | Neri Antonio F | Director | Grant(A) | 440 | — | $0 |
| Mar 10, 2022 | Haytaian Peter D | EVP & Pres., DBG & IngenioRx | Sell(S) | 40 | $463.40 | $19K |
| Mar 10, 2022 | Haytaian Peter D | EVP & Pres., DBG & IngenioRx | Sell(S) | 1K | $462.73 | $574K |
| Mar 10, 2022 | Haytaian Peter D | EVP & Pres., DBG & IngenioRx | Sell(S) | 6K | $461.72 | $2.7M |
| Mar 10, 2022 | Haytaian Peter D | EVP & Pres., DBG & IngenioRx | Option exercise(M) | 2K | $131.80 | $244K |
| Mar 10, 2022 | Haytaian Peter D | EVP & Pres., DBG & IngenioRx | Sell(S) | 4K | $460.68 | $1.9M |
| Mar 10, 2022 | Haytaian Peter D | EVP & Pres., DBG & IngenioRx | Sell(S) | 2K | $458.68 | $995K |
| Mar 10, 2022 | Haytaian Peter D | EVP & Pres., DBG & IngenioRx | Sell(S) | 4K | $459.75 | $2.0M |
| Mar 10, 2022 | Haytaian Peter D | EVP & Pres., DBG & IngenioRx | Option exercise(M) | 2K | — | $0 |
| Mar 3, 2022 | Penczek Ronald W | CAO & Controller | Option exercise(M) | 438 | $311.48 | $136K |
| Mar 3, 2022 | Penczek Ronald W | CAO & Controller | Sell(S) | 2K | $463.68 | $1.1M |
| Mar 3, 2022 | Penczek Ronald W | CAO & Controller | Option exercise(M) | 468 | $307.68 | $144K |
| Mar 3, 2022 | Penczek Ronald W | CAO & Controller | Option exercise(M) | 653 | $271.27 | $177K |
| Mar 3, 2022 | Penczek Ronald W | CAO & Controller | Option exercise(M) | 438 | — | $0 |
| Mar 3, 2022 | Penczek Ronald W | CAO & Controller | Option exercise(M) | 653 | — | $0 |
| Mar 3, 2022 | Penczek Ronald W | CAO & Controller | Option exercise(M) | 468 | — | $0 |
| Mar 2, 2022 | Boudreaux Gail | President and CEO, Director | Tax withholding(F) | 2K | $463.49 | $762K |
| Mar 2, 2022 | Norwood Felicia F | EVP & President, GBD | Tax withholding(F) | 446 | $463.49 | $207K |
| Mar 2, 2022 | Haytaian Peter D | EVP & Pres., DBG & IngenioRx | Tax withholding(F) | 493 | $463.49 | $229K |
| Mar 2, 2022 | Kendrick Charles Morgan JR | EVP & President, Commercial | Tax withholding(F) | 110 | $463.49 | $51K |
| Mar 2, 2022 | McCarthy Gloria M | EVP & Chief Administrative Off | Tax withholding(F) | 487 | $463.49 | $226K |
| Mar 2, 2022 | Gallina John E | EVP & Chief Financial Officer | Gift(G) | 1K | — | $0 |
| Mar 2, 2022 | Gallina John E | EVP & Chief Financial Officer | Tax withholding(F) | 413 | $463.49 | $191K |
| Mar 2, 2022 | Penczek Ronald W | CAO & Controller | Tax withholding(F) | 52 | $463.49 | $24K |
| Mar 1, 2022 | Boudreaux Gail | President and CEO, Director | Grant(A) | 8K | — | $0 |
| Mar 1, 2022 | Boudreaux Gail | President and CEO, Director | Grant(A) | 28K | — | $0 |
| Mar 1, 2022 | Boudreaux Gail | President and CEO, Director | Tax withholding(F) | 15K | $451.50 | $6.9M |
| Mar 1, 2022 | Boudreaux Gail | President and CEO, Director | Grant(A) | 33K | — | $0 |
| Mar 1, 2022 | Norwood Felicia F | EVP & President, GBD | Grant(A) | 2K | — | $0 |
| Mar 1, 2022 | Norwood Felicia F | EVP & President, GBD | Grant(A) | 7K | — | $0 |
| Mar 1, 2022 | Norwood Felicia F | EVP & President, GBD | Tax withholding(F) | 4K | $451.50 | $1.6M |
| Mar 1, 2022 | Norwood Felicia F | EVP & President, GBD | Grant(A) | 9K | — | $0 |
| Mar 1, 2022 | Todt Blair Williams | EVP and Chief Legal Officer | Tax withholding(F) | 191 | $451.50 | $86K |
| Mar 1, 2022 | Todt Blair Williams | EVP and Chief Legal Officer | Grant(A) | 2K | — | $0 |
| Mar 1, 2022 | Todt Blair Williams | EVP and Chief Legal Officer | Grant(A) | 8K | — | $0 |
| Mar 1, 2022 | Haytaian Peter D | EVP & Pres., DBG & IngenioRx | Grant(A) | 8K | — | $0 |
| Mar 1, 2022 | Haytaian Peter D | EVP & Pres., DBG & IngenioRx | Tax withholding(F) | 5K | $451.50 | $2.1M |
| Mar 1, 2022 | Haytaian Peter D | EVP & Pres., DBG & IngenioRx | Grant(A) | 2K | — | $0 |
| Mar 1, 2022 | Haytaian Peter D | EVP & Pres., DBG & IngenioRx | Grant(A) | 9K | — | $0 |
| Mar 1, 2022 | Kendrick Charles Morgan JR | EVP & President, Commercial | Grant(A) | 2K | — | $0 |
| Mar 1, 2022 | Kendrick Charles Morgan JR | EVP & President, Commercial | Grant(A) | 2K | — | $0 |
| Mar 1, 2022 | Kendrick Charles Morgan JR | EVP & President, Commercial | Tax withholding(F) | 804 | $451.50 | $363K |
| Mar 1, 2022 | Kendrick Charles Morgan JR | EVP & President, Commercial | Grant(A) | 8K | — | $0 |
| Mar 1, 2022 | McCarthy Gloria M | EVP & Chief Administrative Off | Grant(A) | 8K | — | $0 |
| Mar 1, 2022 | McCarthy Gloria M | EVP & Chief Administrative Off | Tax withholding(F) | 5K | $451.50 | $2.2M |
| Mar 1, 2022 | McCarthy Gloria M | EVP & Chief Administrative Off | Grant(A) | 2K | — | $0 |
| Mar 1, 2022 | McCarthy Gloria M | EVP & Chief Administrative Off | Grant(A) | 9K | — | $0 |
| Mar 1, 2022 | Gallina John E | EVP & Chief Financial Officer | Grant(A) | 3K | — | $0 |
| Mar 1, 2022 | Gallina John E | EVP & Chief Financial Officer | Grant(A) | 8K | — | $0 |
| Mar 1, 2022 | Gallina John E | EVP & Chief Financial Officer | Tax withholding(F) | 4K | $451.50 | $1.9M |
| Mar 1, 2022 | Gallina John E | EVP & Chief Financial Officer | Grant(A) | 12K | — | $0 |
| Mar 1, 2022 | Penczek Ronald W | CAO & Controller | Grant(A) | 953 | — | $0 |
| Mar 1, 2022 | Penczek Ronald W | CAO & Controller | Grant(A) | 222 | — | $0 |
| Mar 1, 2022 | Penczek Ronald W | CAO & Controller | Tax withholding(F) | 369 | $451.50 | $167K |
| Mar 1, 2022 | Penczek Ronald W | CAO & Controller | Grant(A) | 882 | — | $0 |
| Feb 7, 2022 | Penczek Ronald W | CAO & Controller | Option exercise(M) | 357 | $166.97 | $60K |
| Feb 7, 2022 | Penczek Ronald W | CAO & Controller | Sell(S) | 3K | $453.48 | $1.3M |
| Feb 7, 2022 | Penczek Ronald W | CAO & Controller | Option exercise(M) | 653 | $271.27 | $177K |
| Feb 7, 2022 | Penczek Ronald W | CAO & Controller | Option exercise(M) | 935 | $307.68 | $288K |
| Feb 7, 2022 | Penczek Ronald W | CAO & Controller | Option exercise(M) | 818 | $232.04 | $190K |
| Feb 7, 2022 | Penczek Ronald W | CAO & Controller | Option exercise(M) | 935 | — | $0 |
| Feb 7, 2022 | Penczek Ronald W | CAO & Controller | Option exercise(M) | 653 | — | $0 |
| Feb 7, 2022 | Penczek Ronald W | CAO & Controller | Option exercise(M) | 818 | — | $0 |
| Feb 7, 2022 | Penczek Ronald W | CAO & Controller | Option exercise(M) | 357 | — | $0 |
| Dec 30, 2021 | Stark Leah | EVP & CHRO | Tax withholding(F) | 482 | $467.15 | $225K |
| Dec 30, 2021 | Norwood Felicia F | EVP & President, GBD | Tax withholding(F) | 2K | $467.15 | $819K |
| Dec 1, 2021 | Todt Blair Williams | EVP and Chief Legal Officer | Tax withholding(F) | 79 | $404.65 | $32K |
| Nov 1, 2021 | Kendrick Charles Morgan JR | EVP & President, Commercial | Grant(A) | 525 | — | $0 |
| Nov 1, 2021 | Kendrick Charles Morgan JR | EVP & President, Commercial | Grant(A) | 2K | — | $0 |
| Nov 1, 2021 | Haytaian Peter D | EVP & Pres., DBG & IngenioRx | Grant(A) | 1K | — | $0 |
| Nov 1, 2021 | Haytaian Peter D | EVP & Pres., DBG & IngenioRx | Grant(A) | 5K | — | $0 |
| Oct 28, 2021 | Penczek Ronald W | SVP, Chief Accounting Officer | Sell(S) | 1K | $436.00 | $501K |
| Oct 1, 2021 | Alter Jeffrey D. | EVP, IngenioRx & Anthem Health | Tax withholding(F) | 311 | $375.93 | $117K |
| Sep 4, 2021 | Patel Prakash R | EVP & President, DBG | Tax withholding(F) | 4K | $377.71 | $1.3M |
| Sep 1, 2021 | DeVore Susan D. | Director | Grant(A) | 416 | — | $0 |
| Jul 23, 2021 | Schneider Ryan M. | Director | Buy(P) | 1K | $384.36 | $500K |
| Jul 2, 2021 | Norwood Felicia F | EVP & President, GBD | Tax withholding(F) | 6K | $387.20 | $2.1M |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-13. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).